MedTrace Logo

NEUROENDOCRINE REGULATION OF BONE-FAT CROSSTALK IN OBESITY

NCT06540820 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2024-08-06

No results posted yet for this study

Summary

To study the effect of neuroendocrine dysfunctions on bone health in obesity

Conditions

  • Obesity; Endocrine
  • Pituitary Dysfunction
  • Bone Health

Interventions

DIAGNOSTIC_TEST

Dexa or Biompedance analysis with clinical and biochemical evaluations

All patients will undergo body composition study with DXA or Bioimpedance analysis which are the gold standard to determine % of fat mass and fat free mass, basal biochemical examinations and oral glucose tolerance test (OGTT), and clinical evaluation with waist circumference measurement. Moreover, all patients will undergo REMS ultrasound, TBS and BSI evaluation at DXA scan and hand grip test. In addition, all patients will undergo to clinical evaluation with specific nutritional, physical activity and sleep quality questionnaire assessments and an additional volume of blood.

Sponsors & Collaborators

  • Federico II University

    collaborator OTHER

  • University of Catanzaro

    collaborator OTHER

  • Istituto Auxologico Italiano

    collaborator OTHER

  • IRCCS San Raffaele

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-30
Primary Completion
2025-09-30
Completion
2025-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06540820 on ClinicalTrials.gov